Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 30, 2014

View Archived Issues

ApoE2 gene delivery reduces amyloid burden in the brain of transgenic mice

Genetic diversity affects susceptibility to Ebola virus infection

IOmet Pharma describes novel small-molecule GLUT-1 inhibitors for cancer

BioCryst reports data for BCX-4430 in model of Ebola virus infection

Elios Therapeutics' personalized cancer vaccine cleared for phase IIb testing

Cancer Research UK, CRT and Amgen to study AMG-319 in solid tumors

Roivant Neurosciences acquires SB-742457 from GlaxoSmithKline

Amarantus BioScience's Alzheimer's disease diagnostic available for use in clinical trials

Phylogica and Genentech enter antibacterial discovery collaboration

ADDC and AstraZeneca to support five high-throughput screening proposals

Endo Pharmaceuticals and BioDelivery Sciences submit NDA for Buprenorphine Buccal Film

BioCryst receives orphan drug designation for BCX-4161 for hereditary angioedema

Amarantus receives FDA orphan drug designation for MANF for retinitis pigmentosa

FDA approves supplemental BLA for Gazyva

Takeda submits NDA in Japan for glatiramer acetate

Takecab approved for the treatment of acid-related diseases in Japan

Chugai Pharmaceutical obtains approval of vemurafenib in Japan

Cosentyx approved in Japan for psoriasis and psoriatic arthritis

Vimizim approved in Japan for Morquio A syndrome

European approval for Xpert HIV-1 Viral Load test

Chiesi Farmaceutici patents MAPK 14 inhibitors

CSIR divulges silicon-containing antituberculosis pyrroles

Merck KGaA reports discovery of MST1R inhibitor

FDA approves use of Kalydeco for R117H mutation in cystic fibrosis

Data presented on a new chimeric antigen receptor targeting cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...